In conclusion, HBO improves consciousness, cognitive function, and prognosis in patients with severe or moderate TBI through decreasing TBI-induced hematoma volumes, promoting the recovery of EEG rhythms, and modulating the expression of serum NSE, S100β, GFAP, BDNF, NGF, and VEGF. The gene discussed is NGF; the disease is hematoma.